Sponsor message

New 100% online training course from FishVet Group and Benchmark Knowledge Services on The Health and Welfare of Atlantic Salmon

Vaccine sales edge upwards

21 December 2018, at 9:36am

The Norwegian salmon sector purchased 34.9 million doses of salmon vaccines in November – up from 33.0 million in the same month last year.

The main diseases vaccinated against are furunculosis, vibriosis, coldwater, vibriosis, winter sore, infectious pancreatic necrosis (IPN), pancreas disease (PD) and infectious salmon anaemia (ISA).

Vaccine sales in Norway over the last 12 months
Vaccine sales in Norway over the last 12 months

© Pharmaq

Of the November sales 13.4 million doses were PD-vaccines, 9.0 million of which were the 1-component version, while 1.3 million doses of 7-component ISA-vaccines were sold, according to the latest report on the sector by Pharmaq.

Over the last 12 months in Norway 361.4 million doses of vaccines were sold, up from 346.3 million doses in the 12 months up to the end of November 2017. Of these 130.1 million were PD-vaccines., 6.5 million were 7-component ISA vaccines.

Meanwhile the Norwegian trout sector bought 3.3 million vaccine doses in November compared to 2.9 million in November 2017. Total sales of vaccines to trout over the last 12 months were 23.9 million doses, compared to 20.9 million in November 2017.


The Health and Welfare of Atlantic Salmon course

It is vital that fish farm operatives who are responsible for farmed fish are trained in their health and welfare. This will help to ensure that fish are free from disease and suffering whilst at the same time promote good productivity and comply with legislation.

Find out more